Show
10
20
30
40
results per page
City Shutdown as a Response to COVID-19: Understanding Human Experiences and Mental Health Consequences of the Quarantine in Wuhan
Qian, Yue |
University of British Columbia | Operating Grant | $400,468
CIHR British Columbia 2020
Read More
Sex as a Biological Variable Supplement – Host cellular protein substrates of SARS-CoV-2 proteases
Jan, Eric |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2020
Read More
A rapid review of Opioid Substitution Therapy during major disruptions to medical care
Upshur, Ross E |
Lunenfeld-Tanenbaum Research Institute | Operating Grant | $49,831
CIHR Ontario 2020
Read More
COVID-19: Comprehensive biomarker analysis for prediction of clinical course and patient treatment outcomes (COVID-BEACONS)
Kim, Paul Y |
McMaster University | Operating Grant | $1,173,325
CIHR Ontario 2020
Read More
Sex as a Biological Variable Supplement – Shutting down emerging Coronaviruses in humans now and in the future
Barr, Stephen D |
Western University | Operating Grant | $50,000
CIHR Ontario 2020
Read More
Sex as a Biological Variable Supplement – Identification of biomarkers that predict severity of COVID‑19 patients
Kelvin, David J |
Dalhousie University | Operating Grant | $50,000
CIHR Nova Scotia 2020
Read More
Developing integrated guidelines for health care workers in hospital and primary healthcare facilities in response to Covid-19 pandemic in Low- and Middle-Income Countries (LMICs)
Wei, Xiaolin |
University of Toronto | Operating Grant | $498,188
CIHR Ontario 2020
Read More
Sex as a Biological Variable Supplement – Drug repurposing for the rapid development and evaluation of SARS-CoV-2 antivirals
Côté, Marceline |
University of Ottawa | Operating Grant | $40,000
CIHR Ontario 2020
Read More
A Distinction-Based Study on Equity in COVID‑19 Testing for Manitoba First Nations, Metis and Inuit
Nickel, Nathan C |
University of Manitoba | Operating Grant | $317,917
CIHR Manitoba 2020
Read More
Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19
Ng, Kenneth K |
The University of Calgary | Operating Grant | $416,000
CIHR Alberta 2020
Read More